Cargando…
Stimulus-Responsive Smart Nanoparticles-Based CRISPR-Cas Delivery for Therapeutic Genome Editing
The innovative research in genome editing domains such as CRISPR-Cas technology has enabled genetic engineers to manipulate the genomes of living organisms effectively in order to develop the next generation of therapeutic tools. This technique has started the new era of “genome surgery”. Despite th...
Autores principales: | Naeem, Muhammad, Hoque, Mubasher Zahir, Ovais, Muhammad, Basheer, Chanbasha, Ahmad, Irshad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540563/ https://www.ncbi.nlm.nih.gov/pubmed/34681959 http://dx.doi.org/10.3390/ijms222011300 |
Ejemplares similares
-
Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
por: Naeem, Muhammad, et al.
Publicado: (2020) -
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021) -
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing
Components
por: Kazemian, Pardis, et al.
Publicado: (2022) -
Delivery Aspects of CRISPR/Cas for in Vivo Genome
Editing
por: Wilbie, Danny, et al.
Publicado: (2019) -
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)